Nail Dystrophy
| Nail Dystrophy | |
|---|---|
| Term | Nail Dystrophy |
| Short definition | Nadofaragen Firadenovec - (NA-doh-FAR-uh-jeen FIR-uh-DEH-noh-vek) drug used to treat adults with a certain type of high-risk bladder cancer that has not spread to the muscular layers of the bladder. It is used in patients whose cancer has not improved after treatment with Bacillus Calmette-Guérin (BCG). |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Nail Dystrophy - Abnormal changes in the shape, color, texture, and growth of fingernails or toenails. Nail dystrophy is often caused by an infection or injury to the nail. It can also be caused by certain medical conditions, including psoriasis, eczema, warts, cysts, and some tumors. Changes in the nails can also be a sign of chronic heart, lung, liver or kidney disease. Treatment with certain medications, including chemotherapy drugs, can also cause nail changes. Also called onychodystrophy
External links
- Medical encyclopedia article on Nail Dystrophy
- Wikipedia's article - Nail Dystrophy
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski